eplerenone
Selected indexed studies
- Eplerenone. (Nat Rev Drug Discov, 2003) [PMID:12619638]
- Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial. (J Am Soc Nephrol, 2022) [PMID:35440501]
- Comparative effectiveness and safety of eplerenone and spironolactone in patients with heart failure: a systematic review and meta-analysis. (BMC Cardiovasc Disord, 2024) [PMID:39271992]
_Worker-drafted node — pending editorial review._
Connections
eplerenone is a side effect of
Sources
- Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial. (2022) pubmed
- Eplerenone. (2003) pubmed
- Comparative effectiveness and safety of eplerenone and spironolactone in patients with heart failure: a systematic review and meta-analysis. (2024) pubmed
- When to use spironolactone, eplerenone or finerenone in the spectrum of cardiorenal diseases. (2024) pubmed
- Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. (2003) pubmed
- Eplerenone for hypertension. (2017) pubmed
- Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study). (2020) pubmed
- Eplerenone in hypertension. (2004) pubmed
- Eplerenone repurposing in management of chorioretinopathy: Mechanism, nanomedicine-based delivery applications and future trends. (2022) pubmed
- Eplerenone. Pharmacia. (2003) pubmed